Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]
Saved in:
Main Authors: | Mohammed Fouad Shalaby (Author), Hekma A. Abd El Latif (Author), Mohamed El Yamani (Author), May Ahmed Galal (Author), Sherifa Kamal (Author), Ikhlas Sindi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
by: Mohammed Fouad Shalaby, MD, et al.
Published: (2021) -
Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes
by: Mohammed Ahmed Fouad Shalaby, et al.
Published: (2021) -
Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
by: Pratibha Singh, et al.
Published: (2011) -
Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
by: Lakshmi P. Menon MD, et al.
Published: (2021) -
Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
by: Pratibha Singh, et al.
Published: (2011)